295 related articles for article (PubMed ID: 32571254)
21. S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy.
Qi M; Yi X; Yue B; Huang M; Zhou S; Xiong J
Breast Cancer Res; 2023 May; 25(1):55. PubMed ID: 37217945
[TBL] [Abstract][Full Text] [Related]
22. USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.
Wu Y; Qin J; Li F; Yang C; Li Z; Zhou Z; Zhang H; Li Y; Wang X; Liu R; Tao Q; Chen W; Chen C
J Biol Chem; 2019 Nov; 294(47):17837-17847. PubMed ID: 31624151
[TBL] [Abstract][Full Text] [Related]
23. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway.
Xu J; Han M; Shen J; Guan Q; Bai Z; Lang B; Zhang H; Li Z; Zuo D; Zhang W; Wu Y
Cancer Lett; 2016 Dec; 383(1):9-17. PubMed ID: 27693458
[TBL] [Abstract][Full Text] [Related]
24. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
[TBL] [Abstract][Full Text] [Related]
25. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.
Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J
Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.
Jin Y; Cheng H; Cao J; Shen W
J Cell Biochem; 2019 Nov; 120(11):18629-18639. PubMed ID: 31338872
[TBL] [Abstract][Full Text] [Related]
27. The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinone.
Yang YP; Kuo HS; Tsai HD; Peng YC; Lin YL
Breast Cancer Res; 2005; 7(1):R19-27. PubMed ID: 15642166
[TBL] [Abstract][Full Text] [Related]
28. Ell3 stabilizes p53 following CDDP treatment via its effects on ubiquitin-dependent and -independent proteasomal degradation pathways in breast cancer cells.
Ahn HJ; Kim KS; Shin KW; Lim KH; Kim JO; Lee JY; Kim J; Park JH; Yang KM; Baek KH; Ko JJ; Park KS
Oncotarget; 2015 Dec; 6(42):44523-37. PubMed ID: 26540344
[TBL] [Abstract][Full Text] [Related]
29. Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer.
Zhang Y; Du T; Liu N; Wang J; Zhang L; Cui CP; Li C; Zhang X; Wu B; Zhang J; Jiang W; Zhang Y; Zhang Y; Li H; Li P
Cell Death Dis; 2023 Jun; 14(6):378. PubMed ID: 37369659
[TBL] [Abstract][Full Text] [Related]
30. OTUD3: A Lys6 and Lys63 specific deubiquitinase in early vertebrate development.
Job F; Mai C; Villavicencio-Lorini P; Herfurth J; Neuhaus H; Hoffmann K; Pfirrmann T; Hollemann T
Biochim Biophys Acta Gene Regul Mech; 2023 Mar; 1866(1):194901. PubMed ID: 36503125
[TBL] [Abstract][Full Text] [Related]
31. The expression change of OTUD3-PTEN signaling axis in glioma cells.
Liu YZ; Du XX; Zhao QQ; Jiao Q; Jiang H
Ann Transl Med; 2020 Apr; 8(7):490. PubMed ID: 32395534
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of ubiquitin E3 ligase TNF receptor-associated factor 7 leads to stabilization of p53 in breast cancer.
Wang L; Wang L; Zhang S; Qu G; Zhang D; Li S; Liu S
Oncol Rep; 2013 Jan; 29(1):283-7. PubMed ID: 23128672
[TBL] [Abstract][Full Text] [Related]
33. DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells.
Bi Y; Chen X; Wei B; Wang L; Gong L; Li H; Xiong X; Zhao Y
Theranostics; 2021; 11(13):6355-6369. PubMed ID: 33995662
[No Abstract] [Full Text] [Related]
34. GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
Lin F; Xie YJ; Zhang XK; Huang TJ; Xu HF; Mei Y; Liang H; Hu H; Lin ST; Luo FF; Lang YH; Peng LX; Qian CN; Huang BJ
J Exp Clin Cancer Res; 2019 Apr; 38(1):152. PubMed ID: 30961661
[TBL] [Abstract][Full Text] [Related]
35. USP3 stabilizes p53 protein through its deubiquitinase activity.
Fu S; Shao S; Wang L; Liu H; Hou H; Wang Y; Wang H; Huang X; Lv R
Biochem Biophys Res Commun; 2017 Oct; 492(2):178-183. PubMed ID: 28807825
[TBL] [Abstract][Full Text] [Related]
36. SHARPIN Facilitates p53 Degradation in Breast Cancer Cells.
Yang H; Yu S; Wang W; Li X; Hou Y; Liu Z; Shi Y; Mu K; Niu G; Xu J; Wang H; Zhu J; Zhuang T
Neoplasia; 2017 Feb; 19(2):84-92. PubMed ID: 28063307
[TBL] [Abstract][Full Text] [Related]
37. TSPYL5 suppresses p53 levels and function by physical interaction with USP7.
Epping MT; Meijer LA; Krijgsman O; Bos JL; Pandolfi PP; Bernards R
Nat Cell Biol; 2011 Jan; 13(1):102-8. PubMed ID: 21170034
[TBL] [Abstract][Full Text] [Related]
38. RING finger protein 31 promotes p53 degradation in breast cancer cells.
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Strömblad S; Dahlman-Wright K
Oncogene; 2016 Apr; 35(15):1955-64. PubMed ID: 26148235
[TBL] [Abstract][Full Text] [Related]
39. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis.
Liu K; Xue B; Bai G; Zhang W
Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832
[TBL] [Abstract][Full Text] [Related]
40. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
